Tag: shareholders
Institutions own 36% of Vor Biopharma Inc. (NASDAQ:VOR) shares but private...
Key InsightsVor Biopharma's significant private equity firms ownership suggests that the key decisions are influenced by shareholders from the larger publicThe top 3 shareholders...
Individual investors account for 42% of EBR Systems, Inc.’s (ASX:EBR) ownership,...
Key InsightsEBR Systems' significant individual investors ownership suggests that the key decisions are influenced by shareholders from the larger publicThe top 6 shareholders own...
loanDepot, Inc.’s (NYSE:LDI) market cap surged US$61m last week, private equity...
Key InsightsloanDepot's significant private equity firms ownership suggests that the key decisions are influenced by shareholders from the larger publicPCP Managers, L.P. owns 57%...
Private equity firms in ZeroFox Holdings, Inc. (NASDAQ:ZFOX) are its biggest...
Key InsightsZeroFox Holdings' significant private equity firms ownership suggests that the key decisions are influenced by shareholders from the larger publicThe top 6 shareholders...
Global Indemnity Group, LLC’s (NYSE:GBLI) largest shareholders are private equity firms...
Key InsightsIf you want to know who really controls Global Indemnity Group, LLC (NYSE:GBLI), then you'll have to look at the makeup of its...
Ora Banda Mining Limited’s (ASX:OBM) stock price dropped 13% last week;...
Key InsightsOra Banda Mining's significant private equity firms ownership suggests that the key decisions are influenced by shareholders from the larger public53% of the...
Owning 31% shares,hedge funds owners seem interested in Ovid Therapeutics Inc....
Key InsightsSignificantly high institutional ownership implies Ovid Therapeutics' stock price is sensitive to their trading actions52% of the business is held by the top...
London firms dust off ‘defence manuals’ ahead of private equity offensive
London’s listed firms have been dusting off “defence manuals” and conducting “dry-runs” in recent months as they prepare to fend off unwanted approaches from...
Prelude Therapeutics Incorporated (NASDAQ:PRLD) is definitely on the radar of hedge...
Key InsightsGiven the large stake in the stock by institutions, Prelude Therapeutics' stock price might be vulnerable to their trading decisionsThe top 2 shareholders...
Akoya Biosciences, Inc.’s (NASDAQ:AKYA) market cap touched US$254m last week, benefiting...
Key InsightsSignificant control over Akoya Biosciences by private equity firms implies that the general public has more power to influence management and governance-related decisionsThe...